What changed in this filing

/stocks — the workspaceLOADING

Item 2. Management’s Discussion and Analysis

2024-08-12 compared with 2024-05-13 · 69 added, 35 removed, 127 unchanged (45% of the section changed)

70 unchanged sentences

Issued Accounting Pronouncements

reviewed currently issued pronouncements during the three months ended March 31, 2024, and does not believe that any other recently issued,

reviewed currently issued pronouncements during the six months ended June 30, 2024, and does not believe that any other recently issued,

but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed unaudited

financial statements.

of Operations – Three Months Ended March 31, 2024 Compared to the Three Months Ended March 31, 2023.

of Operations – Three months ended June 30, 2024 Compared to the Three months ended June 30, 2023.

and Marketing Expenses

and marketing (“S&M”) expenses increased by $54,380 to $70,229 for the three months ended June 30, 2024, compared to

$15,849 for the prior period ended June 30, 2023.

The primary increase in (S&M) expenses was the result of an increase in advertising

of $25,944, and an increase in marketing cost of $28,436.

and Administrative Expenses

and administrative (“G&A”) expenses decreased by $1,234,562 to $381,376 for the three months ended March 31, 2024, compared

to $1,615,938 for the prior period ended March 31, 2023.

The primary decrease in G&A expenses was the result of a decrease in fair

value of non-cash stock compensation of $1,309,533, with an overall increase in G&A expenses of $74,971.

and administrative (“G&A”) expenses decreased by $356,347 to $278,844 for the three months ended June 30, 2024, compared

to $635,191 for the prior period ended June 30, 2023.

The primary decrease in G&A expenses was the result of a decrease in fair value

of non-cash stock compensation of $355,455, with an overall increase in G&A expenses of $892.

and Development

and Development (“R&D”) expenses increased by $73,939 to $88,939 for the three months ended March 31, 2024, compared

to $15,000 for the prior period ended March 31, 2023.

and Development (“R&D”) expenses increased by $78,939 to $88,939 for the three months ended June 30, 2024, compared to

$10,000 for the prior period ended June 30, 2023.

This overall increase in R&D expenses was the result of an increase in outside

1 unchanged sentence

and Amortization Expense

and amortization expense for the three months ended March 31, 2024 and 2023 was $1,027 and $1,026, respectively.

and amortization expense for the three months ended June 30, 2024 and 2023 was $1,027 and $1,027, respectively.

Income/(Expenses)

income and (expenses) decreased by $127 to $337 for the three months ended March 31, 2024, compared to $464 for the prior period ended

March 31, 2023.

income and (expenses) decreased by $152 to $297 for the three months ended June 30, 2024, compared to $449 for the prior period ended

June 30, 2023.

The decrease in other income and (expenses) was the result of a decrease in interest income of $152.

The decrease in

other income and (expenses) was primarily due to the net change in interest income.

The decrease in other

income and (expenses) was primarily due to the net change in interest income.

Income (Loss)

net loss for the three months ended March 31, 2024 was $471,004, compared to $1,631,500 for the prior period ended March 31, 2023.

decrease in net loss was due to a decrease in non-cash expense` associated with the net change in stock option expense in the current

These estimates were based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility,

variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based

on management projections.

net loss for the three months ended June 30, 2024 was $438,742, compared to $661,618 for the prior period ended June 30, 2023.

in net loss was due to a decrease in non-cash expense` associated with the net change in stock option expense in the current period.

These estimates were based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable

conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management

These inputs were subject to significant changes from period to period and to management’s judgment;

therefore, the estimated fair value of the stock options fluctuate, and the fluctuation may be material.

The Company has not generated

any revenues.

therefore, the

estimated fair value of the stock options fluctuate, and the fluctuation may be material.

The Company has not generated any revenues.

of Operations – Six months ended June 30, 2024 Compared to the Six months ended June 30, 2023.

and Marketing Expenses

and marketing (“S&M”) expenses increased by $129,351 to $145,200 for the six months ended June 30, 2024, compared to

$15,849 for the prior period ended June 30, 2023.

The primary increase in (S&M) expenses was the result of an increase in marketing

cost of $129,351.

and Administrative Expenses

and administrative (“G&A”) expenses decreased by $1,665,881 to $585,248 for the six months ended June 30, 2024, compared

to $2,251,129 for the prior period ended June 30, 2023.

The primary decrease in G&A expenses was the result of a decrease in fair

value of non-cash stock compensation of $1,753,393, with an overall decrease in G&A expenses of $87,512.

and Development

and Development (“R&D”) expenses increased by $152,878 to $177,878 for the six months ended June 30, 2024, compared to

$25,000 for the prior period ended June 30, 2023.

This overall increase in R&D expenses was the result of an increase in outside

research fees.

and Amortization Expense

and amortization expense for the six months ended June 30, 2024 and 2023 was $2,054 and $2,053, respectively.

Income/(Expenses)

income and (expenses) decreased by $279 to $634 for the six months ended June 30, 2024, compared to $913 for the prior period ended June

The decrease in other income and (expenses) was primarily due to the net change in interest income.

Income (Loss)

net loss for the six months ended June 30, 2024 was $909,746, compared to $2,293,118 for the prior period ended June 30, 2023.

in net loss was due to a decrease in non-cash expense` associated with the net change in stock option expense in the current period.

These estimates were based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable

conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management

These inputs were subject to significant changes from period to period and to management’s judgment;

therefore, the

estimated fair value of the stock options fluctuate, and the fluctuation may be material.

The Company has not generated any revenues.

AND CAPITAL RESOURCES

7 unchanged sentences

financial statements do not reflect any adjustments that might result if we are unable to continue as a going concern.

During the three

months ended March 31, 2024, we did not generate any revenues, and recognized a net loss of $471,341, due to a change in non-cash stock

During the six

months ended June 30, 2024, we did not generate any revenues, and recognized a net loss of $909,746, due to a change in non-cash stock

compensation, and cash of $824,205 used in operations.

As of March 31, 2024, we had working capital of $3,285,252 and a shareholders’

As of June 30, 2024, we had working capital of $2,890,580 and a shareholders’

deficit of $573,277.

7 unchanged sentences

dilution for our stockholders, in case of equity financing.

of March 31, 2024, we had working capital of $3,285,252 compared to $3,678,942 for the year ended December 31, 2023.

of June 30, 2024, we had working capital of $2,890,580 compared to $3,678,942 for the year ended December 31, 2023.

This decrease in

working capital was due primarily to a decrease in cash.

the three months ended March 31, 2024, we used $431,405 of cash for operating activities, as compared to $194,320 for the prior period

ended March 31, 2023.

The increase in the use of cash for operating activities for the current period was a result of an increase in

research and development cost, advertising and marketing, and salaries.

cash provided from equity financing activities for the three months ended March 31, 2024 and March 31, 2023 was $0.

There was no equity

financing during the current or prior period.

Our capital needs have primarily been met from the proceeds of the sale of our securities,

as we currently have not generated any revenues.

the six months ended June 30, 2024, we used $824,205 of cash for operating activities, as compared to $422,098 for the prior period ended

June 30, 2023.

The increase in the use of cash for operating activities for the current period was a result of an increase in research

and development cost, advertising and marketing, and salaries.

cash provided from equity financing activities for the six months ended June 30, 2024 and June 30, 2023 was $0.

There was no equity financing

during the current or prior period.

Our capital needs have primarily been met from the proceeds of the sale of our securities, as we

currently have not generated any revenues.

independent auditors, in their report on our audited financial statements for the year ended December 31, 2023, expressed substantial

1 unchanged sentence

Our financial statements as of

March 31, 2024 have been prepared under the assumption that we will continue as a going concern.

June 30, 2024 have been prepared under the assumption that we will continue as a going concern.

Our ability to continue as a going concern

20 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Management’s Discussion and Analysis